IDO1 and cancer: An NLG919-mediated inhibition of IDO1 in the NLG/Oxa (IV), liposomes can effectively prevent the depletion of tryptophan to immunosuppressive kynurenine in cancer cells, as well as release the cytotoxic oxaliplatin into the cytosol to induce immunogenic cell death (ICD).